IRINA KORNEEVA-VLADIMIRSKY: Open Payments
NPI 1437321460 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,928 in 78 payments from 20 companies in 2025. Trend: 2023 $1,752 · 2024 $1,772 · 2025 $1,928
Food & beverage: $1,860Education: $68
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 8 | $251 |
| ABBVIE INC. | 11 | $207 |
| Aimmune Therapeutics, Inc. | 3 | $200 |
| PFIZER INC. | 8 | $171 |
| Amgen Inc. | 7 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $123 |
| Axsome Therapeutics, Inc. | 5 | $122 |
| AstraZeneca Pharmaceuticals LP | 4 | $100 |
| Kowa Pharmaceuticals America, Inc. | 5 | $98 |
| Astellas Pharma US Inc | 2 | $90 |
Products named: IBSRELA, ZENPEP, NURTEC ODT, EVENITY, XIFAXAN, Symbravo, ZORYVE, Leqembi.
Industry payments across NY — which companies pay providers there.
